Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1371/journal.pone.0152760
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2016
- Urheber
-
Rosenberg, Yvonne J.
Montefiori, David C.
LaBranche, Celia C.
Lewis, Mark G.
Sack, Markus
Lees, Jonathan P.
Jiang, Xiaoming
- DOI
-
10.18154/RWTH-2017-01257
- URN
-
urn:nbn:de:101:1-2018101606071772739113
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rosenberg, Yvonne J.
- Montefiori, David C.
- LaBranche, Celia C.
- Lewis, Mark G.
- Sack, Markus
- Lees, Jonathan P.
- Jiang, Xiaoming
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2016
Ähnliche Objekte (12)
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Antibody technologies and protein engineering for the generation of novel antibody-derived entities with therapeutic potential
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Antibody technologies and protein engineering for the generation of novel antibody-derived entities with therapeutic potential
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity
Identification of a novel broadly neutralizing antibody targeting HIV-1
Mechanisms of sterilizing immunity after passive immunization with an HIV neutralizing antibody
Restriction of hiv-1 escape by a highly broad and potent neutralizing antibody
Restriction of HIV-1 escape by a novel highly broad and potent neutralizing antibody
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
A neutralizing IL-11 antibody reduces vessel hyperplasia in a mouse carotid artery wire injury model
Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
Antibody technologies and protein engineering for the generation of novel antibody-derived entities with therapeutic potential
Neutralizing antibody formation with onabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: a meta-analysis